Title: Total Cholesterol and Triglyceride Level in Patients of Chronic Kidney Disease

Authors: Arvind Kumar, Ranjit Kumar Nim, Vinay Kumar Verma, Prem Singh, S.K. Gautam

 DOI: https://dx.doi.org/10.18535/jmscr/v8i5.95

Abstract

 

Background: The high prevalence of total cholesterol and triglyceride level in chronic kidney disease (CKD) patients reveals significant association between CKD and dyslipidemia.

Objectives:  The aim of study the total cholesterol and triglyceride levelin patients of CKD and study the correlation between total cholesterol, triglycerides and severity of renal diseases.

Materials and Methods: A cross-sectional study were conducted among CKD patients attending OPD and admitted in Medicine department of GSVM Medical College, Kanpur from January 2018 to October 2019 to investigate thyroid function and lipid profile in CKD stage 3–5. A total of 100 newly diagnosed and known CKD cases (stage 3 to stage 5) would be included in the study.

Result: Correlation between triglycerides of case and control where mean of control group is99.05±18.93, and case group is 180.61±89.77 where p value is 0.0001.correlation between serum total cholesterol of case and control group where mean of control group is 139.58±20.84, and case group is 167.49±18.24, where p value is 0.0001.

Conclusion: The correlation of Total Cholesterol and Triglycerides in CKD patients is found to be highly significant.

Keyword: Chronic Kidney Disease, Triglycerides, Total Cholesterol.

References

  1. Afsar B. Dyslipidemias in chronic kidney disease: current guidelines and future perspectives. OA Nephrology. 2013;1(1):2.
  2. Chen SC, Hung CC, Kuo MC, Lee JJ, Chiu YW, et al. Association of dyslipidemia with renal outcomes in chronic kidney disease. Plos One. 2013; 8(2):e55643.
  3. Olechnowicz-Tietz S, Gluba A, Paradowska A, Banach M, Rysz J. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol. 2013;45(6):1605–12.
  4. Saroj Khatiwada, Rajendra KC, Sharad Gautam, Madhab Lamsal, and Nirmal Baral: Thyroid dysfunction and dyslipidemia in chronic kidney disease patients. BMC Endocr Disord. 2015; 15: 65.
  5. Tsimihodimos V, Mitrogianni Z, Elisaf M. Dyslipidemia associated with chronic kidney disease. Open Cardiovasc Med J. 2011;5:41–8.
  6. Kim JY et al, Comparison of lipid-related ratios for prediction of chronic kidney disease stage 3 or more in Korean adults. DOI:10.3346/jkms.2012.27.12.152.
  7. Tsuruya K et al Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population. DOI:10.1016/j.atherosclerosis.2013.12.037
  8. Zavidić T et al(2016) studied use of statins in patients with chronic kidney disease to prevent cardiovascular diseaseacta Med Croatica. 2016 Dec;70(4-5):301-7
  9. S.S.K.bRaju et al (2013) studied Lipid Profile and Lipid Peroxidation in Chronic Kidney Disease patients  J Clinic Res Bioeth 4: 143. Doi:10.4172/2155-9627.1000143.

Corresponding Author

Arvind Kumar

Associate Professor, Department of Internal Medicine, GSVM Medical College